Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Submitted by
admin
on December 12, 2013 - 4:15pm
Source:
Fierce Biotech
News Tags:
FDA
advisory panels
Bristol-Myers Squibb
metreleptin
AstraZeneca
partial lipodystrophy
Headline:
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Do Not Allow Advertisers to Use My Personal information
